Drug factory · FDA FEI 3007373503

Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)

38 Huanghe Road, Economic and Technological Development Zone, , Lianyungang, China

China: 1

Serious problems, FDA action at FDA's last inspection, Jan 16, 2024.

Official Action Indicated: inspectors found significant problems and FDA recommended regulatory action, such as a warning letter or import alert.

5 drug inspections on record since 2012: 2 with no problems, 2 with problems fixed voluntarily, 1 with FDA action.

What it does, for whom

DrugRoleForNDC
CarmustineMakes it, tests it, packages it, labels it and sterilizes it Sandoz Inc. 0781-3474
Gadolinium Cation (3+)Makes it Fresenius Kabi USA, LLC 65219-080, 65219-082, 65219-084 +2
OxaliplatinMakes it Sagent Pharmaceuticals 25021-233

FDA inspection history

EndedResultProgramProblems noted
Jan 16, 2024Serious problems, FDA actionDrug Quality Assurance—
May 14, 2018Problems found, fixed voluntarilyDrug Quality Assurance—
Nov 2, 2016Problems found, fixed voluntarilyDrug Quality Assurance—
May 13, 2014No problems foundDrug Quality Assurance—
Jul 26, 2012No problems foundDrug Quality Assurance—

Registered with FDA for: analysis; label; manufacture; pack; sterilize.